An assay procedure for single antigens such as Fel d I, Bla g I and Bla g II, using monoclonal antibodies, has been transferred from the absorbance system to a fluorescent system, improving the sensitivity of these tests by several fold. However, recent refinements in an ELISA method, utilizing non-fluorescent detection methods has indicated that this test may also be useful as a method to measure the relative potency of allergenic extracts. Development of these two systems will continue in order to provide statistical limits for each assay. Comparison of these two potency assays to the RAST inhibition method currently employed for release of products will also continue.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BA001006-04
Application #
3804576
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost